Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital

Overall, 94 patients underwent coronary angiography with the intent of PCI (of whom 88 received >1 stent or balloon angioplasty) for ST-segment elevation myocardial infarction (STEMI) in 49 patients, non-ST-segment elevation acute coronary syndromes (ACS) in 38, and stable angina in 7. Â Single-C...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2017-01, Vol.69 (4), p.463-464
Main Authors: Vaduganathan, Muthiah, Qamar, Arman, Singh, Abhayjit, Venkateswaran, Ramkumar V., Szumita, Paul M., Croce, Kevin J., Mauri, Laura, Leopold, Jane A., Shah, Pinak B., Sobieszczyk, Piotr, Faxon, David P., Bhatt, Deepak L.
Format: Article
Language:English
Subjects:
Acute coronary syndromes
Angina pectoris
Blood platelets
Cardiology
Drug dosages
Electrocardiography
FDA approval
Glycoproteins
Heart attacks
Patients
Stents
Surgery
Thrombosis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Overall, 94 patients underwent coronary angiography with the intent of PCI (of whom 88 received >1 stent or balloon angioplasty) for ST-segment elevation myocardial infarction (STEMI) in 49 patients, non-ST-segment elevation acute coronary syndromes (ACS) in 38, and stable angina in 7.  Single-Center Real-World Experience (n = 100) Pooled CHAMPION Trials[low *] (n = 12,475) Demographic characteristics   Age, yrs 64.0 (55-73) 63.0 (55-71) Female 31 27.6 Medical history   Diabetes mellitus 30 29.3 Prior stroke or transient ischemic attack 6 5.2 History of heart failure 13 8.7 History of peripheral artery disease 11 7.1 Indication for cangrelor use   ST-segment elevation myocardial infarction 49 11.3 Non-ST-segment elevation acute coronary syndrome 38 57.3 Stable angina 7 31.4 Other 6 0 Patient presentation   Cardiogenic shock 16 --
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2016.11.017